ViaDerma, Inc. (OTCMKTS:VDRM) Sees Large Drop in Short Interest

ViaDerma, Inc. (OTCMKTS:VDRM) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 4,800 shares, a decrease of 92.7% from the February 29th total of 65,800 shares. Based on an average trading volume of 2,553,200 shares, the short-interest ratio is currently 0.0 days.

ViaDerma Trading Down 6.5 %

Shares of VDRM stock opened at 0.01 on Thursday. ViaDerma has a 1-year low of 0.01 and a 1-year high of 0.03. The firm’s 50-day simple moving average is 0.01 and its 200-day simple moving average is 0.01.

About ViaDerma

ViaDerma, Inc operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.